Joel Rothman's most recent trade in Equillium Inc was a trade of 175,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Equillium Inc | Rothman Joel | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 175,000 | 175,000 | - | - | Employee Stock Option (right to buy) | |
Equillium Inc | Joel Rothman | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.56 per share. | 02 Jan 2024 | 15,000 | 49,346 (0%) | 0% | 0.6 | 8,400 | Common Stock |
Equillium Inc | Rothman Joel | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.58 per share. | 02 Jan 2024 | 8,804 | 58,150 (0%) | 0% | 0.6 | 5,106 | Common Stock |
Equillium Inc | Joel Rothman | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 175,000 | 175,000 | - | - | Employee Stock Option (right to buy) | |
Equillium Inc | Joel Rothman | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 1.85 per share. | 03 Jan 2023 | 6,244 | 30,525 (0%) | 0% | 1.8 | 11,551 | Common Stock |
Equillium Inc | Joel Rothman | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 1.19 per share. | 03 Jan 2023 | 3,821 | 34,346 (0%) | 0% | 1.2 | 4,547 | Common Stock |
Equillium Inc | Joel Rothman | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
Equillium Inc | Joel Rothman | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 2.35 per share. | 10 Dec 2021 | 1,290 | 24,281 (0%) | 0% | 2.4 | 3,032 | Common Stock |
Equillium Inc | Joel Rothman | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 2.35 per share. | 10 Jun 2021 | 7,742 | 22,991 (0%) | 0% | 2.4 | 18,194 | Common stock, par value $0.0001 per share |